Targeting senescent hepatocytes using the thrombomodulin-PAR1 inhibitor vorapaxar ameliorates NAFLD progression.
Autor: | Maeso-Díaz, Raquel, Kuo Du, Pan, Christopher, Guy, Cynthia D., Seh Hoon Oh, Tianyi Chen, Liuyang Wang, Ko, Dennis C., Tang, Linda, Dutta, Rajesh K., Ji Hye Jun, Ayako Suzuki, Abdelmalek, Manal F., Xiao-Fan Wang, Diehl, Anna Mae |
---|---|
Zdroj: | Hepatology (02709139); Oct2023, Vol. 78 Issue 4, p1209-1222, 14p |
Databáze: | Complementary Index |
Externí odkaz: |